Response to Targownik

Affiliations

¹ 1] Gastroenterology Department, Centro Hospitalar São João, Porto, Portugal [2] Institute of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto Portugal, Porto, Portugal [3] IBMC-Institute for Molecular and Cell Biology, University of Porto, Porto, Portugal.
² Gastroenterology Department, Centro Hospitalar São João, Porto, Portugal.
³ CIDES-Department of Health Information and Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.

Comment

Fernando Magro et al. Am J Gastroenterol. 2015 Feb.

. 2015 Feb;110(2):349-51.

doi: 10.1038/ajg.2014.376.

¹ 1] Gastroenterology Department, Centro Hospitalar São João, Porto, Portugal [2] Institute of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto Portugal, Porto, Portugal [3] IBMC-Institute for Molecular and Cell Biology, University of Porto, Porto, Portugal.
² Gastroenterology Department, Centro Hospitalar São João, Porto, Portugal.
³ CIDES-Department of Health Information and Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.

No abstract available

Comment on

Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
Magro F, Rodrigues-Pinto E, Coelho R, Andrade P, Santos-Antunes J, Lopes S, Camila-Dias C, Macedo G. Magro F, et al. Am J Gastroenterol. 2014 Jul;109(7):1026-36. doi: 10.1038/ajg.2014.97. Epub 2014 May 6. Am J Gastroenterol. 2014. PMID: 24796767
The importance of accounting for immortal time bias in pharmacoepidemiologic analyses.
Targownik L. Targownik L. Am J Gastroenterol. 2015 Feb;110(2):349. doi: 10.1038/ajg.2014.372. Am J Gastroenterol. 2015. PMID: 25646915 No abstract available.